8-Chloro[1,2,4]triazolo[1,5-a]pyrazin-2-amine, 97%, 1g

(S)-1,4-Dioxane-2-carboxylic acid, 95.0%, 250mg

1-(4-Methylphenyl)butan-2-one, 97.0%, 10g

2-(Piperidin-4-yl)benzo[d]thiazole, 95.0%, 5g

4-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine, 95.0%, 250mg

5-Methylsulfonyl-2-[((S)-2,2,2-trifluoro-1-methylethyl)oxy]benzoic acid methyl ester, 98%, 500mg

1-(TERT-BUTOXYCARBONYL)-3-FLUOROPYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 1g

(S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]100mg

2-Acetyl-6-methoxypyridine, 95.0%, 5g

(Sulfonylbis(methylene))dibenzene, 95+%, 25g

N-Acetyl-L-glutamic Acid>98.0%(HPLC)(T)250g

5-Ethyl-2-methyl-nicotinic acid ethyl ester, 95.0%, 1g

tert-Butyl 2-chloro-4-methyl-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate, 97%, 250mg